{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:47:02Z","timestamp":1788904022876,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2025.11.031","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:07:52Z","timestamp":1764346072000},"page":"1503-1519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["C\/EBP\u03b2 stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-2567","authenticated-orcid":false,"given":"Kevin","family":"Holm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-sun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Z.","family":"Samara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Swiderski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Alluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagy","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.11.031_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of triple-negative breast cancer: A review","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.ymthe.2025.11.031_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-019-0682-x","article-title":"Targeted therapies for triple-negative breast cancer","volume":"20","author":"Lyons","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tcb.2007.07.004","article-title":"The C\/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control","volume":"17","author":"Nerlov","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrd1345","article-title":"siRNAs: applications in functional genomics and potential as therapeutics","volume":"3","author":"Dorsett","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.11.031_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ymthe.2025.11.031_bib6","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1093\/nar\/gks294","article-title":"Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers","volume":"40","author":"Thiel","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addr.2018.04.005","article-title":"Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers","volume":"134","author":"Zhou","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.11.031_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.11.031_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type\u2013specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1172\/JCI33365","article-title":"Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice","volume":"118","author":"McNamara","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.11.031_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.omtn.2017.12.021","article-title":"STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma","volume":"10","author":"Esposito","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.11.031_bib12","doi-asserted-by":"crossref","first-page":"32360","DOI":"10.1021\/acsami.0c07353","article-title":"Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+ Breast Cancer","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ymthe.2025.11.031_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41392-020-0197-8","article-title":"Addiction to protein kinase C\u0269 due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer","volume":"5","author":"Rehmani","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.11.031_bib14","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/pr700894d","article-title":"Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells","volume":"7","author":"Shangguan","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","article-title":"Therapeutic implications of cancer stem cells","volume":"14","author":"Al-Hajj","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ymthe.2025.11.031_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells \u2014 what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.11.031_bib17","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.3390\/ijms21124308","article-title":"The \u201cJanus\u201d Role of C\/EBPs Family Members in Cancer Progression","volume":"21","author":"Tolomeo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.11.031_bib18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1182\/blood.V80.7.1725.1725","article-title":"A novel temporal expression pattern of three C\/EBP family members in differentiating myelomonocytic cells","volume":"80","author":"Scott","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.11.031_bib19","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1242\/jcs.02459","article-title":"Molecular stop signs: regulation of cell-cycle arrest by C\/EBP transcription factors","volume":"118","author":"Johnson","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymthe.2025.11.031_bib20","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1038\/onc.2017.151","article-title":"A tumor suppressor role for C\/EBP\u03b1 in solid tumors: more than fat and blood","volume":"36","author":"Louren\u00e7o","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.11.031_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pros.20947","article-title":"In prostate cancer C\/EBP\u03b1 promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT","volume":"69","author":"Yin","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2025.11.031_bib22","first-page":"1974","article-title":"Association of the invasiveness of colon cancer with the expression of C\/EBP\u03b1","volume":"17","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ymthe.2025.11.031_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2022.100861","article-title":"CCAAT enhancer binding protein gamma (C\/EBP-\u03b3): An understudied transcription factor","volume":"84","author":"Renfro","year":"2022","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.ymthe.2025.11.031_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2867-10-48","article-title":"CCAAT\/Enhancer Binding Protein-delta (C\/EBP-delta) regulates cell growth, migration and differentiation","volume":"10","author":"Yu","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2025.11.031_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41523-021-00372-z","article-title":"C\/EBP\u03b2 isoform-specific regulation of migration and invasion in triple-negative breast cancer cells","volume":"8","author":"Sterken","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ymthe.2025.11.031_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.11.031_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110752","article-title":"Regulation of senescence and the SASP by the transcription factor C\/EBP\u03b2","volume":"128","author":"Salotti","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib28","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1158\/1535-7163.MCT-21-0019","article-title":"C\/EBP\u03b2\/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers","volume":"20","author":"Lei","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.11.031_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/pros.23749","article-title":"Prostate cancer induces C\/EBP\u03b2 expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome","volume":"79","author":"Adamo","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.ymthe.2025.11.031_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-4-43","article-title":"C\/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells","volume":"4","author":"Bundy","year":"2005","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.11.031_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025205","article-title":"Negative Regulation of C\/EBPbeta1 by Sumoylation in Breast Cancer Cells","volume":"6","author":"Atwood","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.11.031_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2010.09.021","article-title":"Characterization of the transcriptional signature of C\/EBPbeta isoforms (LAP\/LIP) in Hep3B cells: Implication of LIP in pro-survival functions","volume":"54","author":"Saint-Auret","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib33","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1101\/gad.14.15.1920","article-title":"Translational control of C\/EBP\u03b1 and C\/EBP\u03b2 isoform expression","volume":"14","author":"Calkhoven","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2025.11.031_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yexcr.2014.05.019","article-title":"CCAAT\/enhancer binding protein beta (C\/EBP\u03b2) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells","volume":"327","author":"Miura","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib35","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.12659\/MSM.916886","article-title":"Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) promotes hypoxia-induced invasion and metastasis in ovarian cancer by targeting matrix metallopeptidase 13 (MMP13)","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymthe.2025.11.031_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/hmg\/ddr540","article-title":"C\/EBP\u03b2 and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2\u03b1 as the inducer in chondrocytes","volume":"21","author":"Hirata","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.031_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.placenta.2015.06.016","article-title":"Oxidative stress-induced C\/EBP\u03b2 inhibits \u03b2-catenin signaling molecule involving in the pathology of preeclampsia","volume":"36","author":"Zhuang","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ymthe.2025.11.031_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103208","article-title":"Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives","volume":"73","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib39","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1158\/1535-7163.MCT-21-0019","article-title":"C\/EBP\u03b2\/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis","volume":"20","author":"Lei","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.11.031_bib40","series-title":"Current Topics in Cellular Regulation","first-page":"117","article-title":"Superoxide dismutase, oxidative stress, and cell metabolism","author":"Culotta","year":"2001"},{"key":"10.1016\/j.ymthe.2025.11.031_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.215906","article-title":"Cellular evaluation of superoxide dismutase mimics as catalytic drugs: Challenges and opportunities","volume":"514","author":"Schanne","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ymthe.2025.11.031_bib42","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymthe.2025.11.031_bib43","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/antiox13050591","article-title":"Oxidative Stress, Lipid Peroxidation and Ferroptosis Are Major Pathophysiological Signatures in the Placental Tissue of Women with Late-Onset Preeclampsia","volume":"13","author":"Ortega","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ymthe.2025.11.031_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103208","article-title":"Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives","volume":"73","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbrc.2019.05.098","article-title":"Oxidative stress induces senescence in breast cancer stem cells","volume":"514","author":"Zhong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2025.11.031_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2021.05.002","article-title":"ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs)","volume":"165","author":"Kuczler","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2024.08.002","article-title":"AMPK: The energy sensor at the crossroads of aging and cancer","volume":"106\u2013107","author":"Penugurti","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/plants4030393","article-title":"Senescence, Stress, and Reactive Oxygen Species","volume":"4","author":"Jajic","year":"2015","journal-title":"Plants"},{"key":"10.1016\/j.ymthe.2025.11.031_bib50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bcp.2008.12.016","article-title":"Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin","volume":"77","author":"Di","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.674354","article-title":"Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies","volume":"11","author":"Chakrabarty","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/biology9120485","article-title":"The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases","volume":"9","author":"Cuollo","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.ymthe.2025.11.031_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110752","article-title":"Regulation of senescence and the SASP by the transcription factor C\/EBP\u03b2","volume":"128","author":"Salotti","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2753","article-title":"A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer","volume":"12","author":"Yau","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib93","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-10-r215","article-title":"High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer","volume":"8","author":"Chin","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.ymthe.2025.11.031_bib54","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41388-021-01788-4","article-title":"C\/EBP\u03b2 promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer","volume":"40","author":"Tan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.11.031_bib55","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/cdd.2012.41","article-title":"MKP-1 antagonizes C\/EBP \u03b2 activity and lowers the apoptotic threshold after ischemic injury","volume":"19","author":"Rininger","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.11.031_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj8658","article-title":"Neuronal C\/EBP\u03b2\/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression","volume":"8","author":"Xia","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.11.031_bib57","first-page":"btz854","article-title":"RaNA-Seq: interactive RNA-Seq analysis from FASTQ files to functional analysis","volume":"36","author":"Prieto","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.11.031_bib58","article-title":"The physiological characteristics of inward rectifying potassium channel Kir4.2 and its research progress in human diseases","volume":"13","author":"Zhang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib59","article-title":"Cell Settling, Migration, and Stochastic Cancer Expression Suggest Potassium Flux Per H+ - Sensitive KCN Members Associated with Oncogenes and Histone\/DNA Modulators Potentially Initiates pH-Reversal","author":"Beckner","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.11.031_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv046","article-title":"The Role of C\/EBP-\u03b2 LIP in Multidrug Resistance","volume":"107","author":"Riganti","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ymthe.2025.11.031_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41467-021-27734-2","article-title":"C\/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.11.031_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2016.06.050","article-title":"Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy","volume":"333","author":"Duggett","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2025.11.031_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2478\/v10039-012-0063-1","article-title":"Oxidative stress induced in rat liver by anticancer drugs doxorubicin, paclitaxel and docetaxel","volume":"58","author":"Pieni\u0105\u017cek","year":"2013","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.ymthe.2025.11.031_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","article-title":"Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymthe.2025.11.031_bib65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12951-025-03406-x","article-title":"Oxidative stress induced paclitaxel-derived carbon dots inhibit glioblastoma proliferation and EMT process","volume":"23","author":"Yan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib66","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1111\/jcmm.15487","article-title":"LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C\/EBP\u03b2","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.11.031_bib67","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1158\/0008-5472.CAN-05-1162","article-title":"Resistance to Paclitaxel Is Proportional to Cellular Total Antioxidant Capacity","volume":"65","author":"Ramanathan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib68","article-title":"Long Noncoding RNAs in Taxane Resistance of Breast Cancer","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.11.031_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molimm.2017.09.008","article-title":"Expression of C\/EBP\u03b2 in myeloid progenitors during sepsis promotes immunosuppression","volume":"91","author":"Dai","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib70","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/2211-5463.13138","article-title":"C\/EBP\u03b2 regulates the JAK\/STAT signaling pathway in triple-negative breast cancer","volume":"11","author":"Wang","year":"2021","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.ymthe.2025.11.031_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/biom15010036","article-title":"C\/EBP\u03b2 Regulates HIF-1\u03b1-Driven Invasion of Non-Small-Cell Lung Cancer Cells","volume":"15","author":"Seo","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2025.11.031_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1025900908026","article-title":"The Role of C\/EBP\u03b2 in Mammary Gland Development and Breast Cancer","volume":"8","author":"Grimm","year":"2003","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ymthe.2025.11.031_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1111522","article-title":"Emerging functions of C\/EBP\u03b2 in breast cancer","volume":"13","author":"Matherne","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib75","article-title":"Lacidipine Ameliorates the Endothelial Senescence and Inflammatory Injury Through CXCR7\/P38\/C\/EBP-\u03b2 Signaling Pathway","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ymthe.2025.11.031_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s10020-023-00752-0","article-title":"IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in d-galactose-induced aging mice","volume":"29","author":"Zhou","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymthe.2025.11.031_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199105","article-title":"Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens","volume":"13","author":"Srivastava","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113861","article-title":"Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy","volume":"156","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.11.031_bib79","first-page":"1361","article-title":"Immunohistochemical Profile and Morphology in Triple \u2013 Negative Breast Cancers","volume":"7","author":"Rao","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib80","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-022-02476-1","article-title":"Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications","volume":"41","author":"Asleh","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib82","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.gendis.2022.03.010","article-title":"Cancer genes and cancer stem cells in tumorigenesis: Evolutionary deep homology and controversies","volume":"9","author":"Niculescu","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.ymthe.2025.11.031_bib83","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.3390\/ijms24076196","article-title":"Systemic Alterations of Cancer Cells and Their Boost by Polyploidization: Unicellular Attractor (UCA) Model","volume":"24","author":"Vinogradov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.11.031_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.031_bib85","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cac2.12316","article-title":"The theory of tumor ecosystem","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ymthe.2025.11.031_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1950","article-title":"Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer","volume":"16","author":"Cao","year":"2024","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2025.11.031_bib88","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/bcr2902","article-title":"Stat3 and CCAAT\/enhancer binding protein beta (C\/EBP-beta) regulate Jab1\/CSN5 expression in mammary carcinoma cells","volume":"13","author":"Shackleford","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2025.11.031_bib89","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1038\/s41467-024-52820-6","article-title":"Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence","volume":"15","author":"Daigh","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:37:25Z","timestamp":1776371845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001625010184"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.031","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\/EBP\u03b2 stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}